These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38735056)

  • 1. Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology.
    Kotredes KP; Pandey RS; Persohn S; Elderidge K; Burton CP; Miner EW; Haynes KA; Santos DFS; Williams SP; Heaton N; Ingraham CM; Lloyd C; Garceau D; O'Rourke R; Herrick S; Rangel-Barajas C; Maharjan S; Wang N; Sasner M; Lamb BT; Territo PR; Sukoff Rizzo SJ; Carter GW; Howell GR; Oblak AL
    Alzheimers Dement; 2024 Jun; 20(6):4126-4146. PubMed ID: 38735056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology.
    Kotredes KP; Pandey RS; Persohn S; Elderidge K; Burton CP; Miner EW; Haynes KA; Santos DFS; Williams SP; Heaton N; Ingraham CM; Lloyd C; Garceau D; O'Rourke R; Herrick S; Rangel-Barajas C; Maharjan S; Wang N; Sasner M; Lamb BT; Territo PR; Sukoff Rizzo SJ; Carter GW; Howell GR; Oblak AL
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
    Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
    Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer's disease.
    Qian Z; Wang Z; Li B; Meng X; Kuang Z; Li Y; Yang Y; Ye K
    Mol Psychiatry; 2024 Oct; 29(10):3040-3055. PubMed ID: 38658772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer's disease.
    Wang J; Huang Q; Chen X; You Z; He K; Guo Q; Huang Y; Yang Y; Lin Z; Guo T; Zhao J; Guan Y; Li B; Xie F
    Mol Psychiatry; 2024 Sep; 29(9):2799-2809. PubMed ID: 38589563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.
    Zeng X; Lafferty TK; Sehrawat A; Chen Y; Ferreira PCL; Bellaver B; Povala G; Kamboh MI; Klunk WE; Cohen AD; Lopez OL; Ikonomovic MD; Pascoal TA; Ganguli M; Villemagne VL; Snitz BE; Karikari TK
    Mol Neurodegener; 2024 Oct; 19(1):68. PubMed ID: 39385222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer's disease.
    Pandey RS; Kotredes KP; Sasner M; Howell GR; Carter GW
    BMC Genomics; 2023 Apr; 24(1):172. PubMed ID: 37016304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term High-Fat Diet Consumption Aggravates β-Amyloid Deposition and Tau Pathology Accompanied by Microglial Activation in an Alzheimer's Disease Model.
    Liang Z; Gong X; Zhao Y; Zhao Y; Yu J; Huang T; Yang C; Wu L; Huang M; Wang X; Shu X; Bao J
    Mol Nutr Food Res; 2024 Apr; 68(7):e2300669. PubMed ID: 38491393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.
    Knight EM; Martins IV; Gümüsgöz S; Allan SM; Lawrence CB
    Neurobiol Aging; 2014 Aug; 35(8):1821-32. PubMed ID: 24630364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.
    Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F
    J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.